Iovance Biotherapeutics
IOVA
IOVA
251 hedge funds and large institutions have $380M invested in Iovance Biotherapeutics in 2025 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 92 increasing their positions, 72 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
52% less capital invested
Capital invested by funds: $798M → $380M (-$418M)
55% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 82
Holders
251
Holding in Top 10
1
Calls
$3.58M
Puts
$2.55M
Top Buyers
| 1 | +$15.8M | |
| 2 | +$7.83M | |
| 3 | +$7.29M | |
| 4 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$4.82M |
| 5 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$4.42M |
Top Sellers
| 1 | -$42.3M | |
| 2 | -$30.7M | |
| 3 | -$16M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$14.7M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$9.02M |
